R6 · free executive summary
the unit, the currency, and what 'international' actually buys
Executive summary · free edition · September 2026
Complete in itself. The finding is here, not held back to make you buy the report.
We set out to show that an American index fund already carries more foreign exposure than the international fund bought to diversify it.
It does not, and we are printing that first.
Measured on where revenue is actually earned, the American index's top ten earns 47.20% abroad. The international index's top ten earns 74.48% to 74.85%. The international fund's largest holdings earn 1.58 times as much foreign revenue. The strong claim is dead.
The home-bias argument is conducted in the wrong unit.
| American index, top ten | International index, top ten | |
|---|---|---|
| On where the company is listed | 0% foreign | 100% foreign |
| On where the revenue is earned | 47.20% foreign | 74.48–74.85% foreign |
On listing, the two funds are 100 points apart. On revenue, 27.29. Changing the unit erases roughly 72% of the apparent difference.
And the reverse leg stands on its own. A quarter of the international index's top-ten revenue is earned in the United States. Three European pharmaceutical companies each earn a larger share of their revenue in America than Apple or Meta do:
| Revenue earned in the United States | |
|---|---|
| Roche | 47.96% |
| Novartis | 42.78% |
| AstraZeneca | 40.81% |
| Meta | 37.21% |
| Apple | 36.47% |
An investor holding the European names for geographic diversification and the American names as domestic exposure has the relationship backwards on the measure that describes where the money comes from.
Compare the same international index hedged and unhedged. Identical stock selection. The only difference is the currency hedge.
| Period | Hedged advantage |
|---|---|
| 1 year | +7.63 points |
| 10 years | +3.24 points a year |
Calendar years are louder: hedging won by 8.17, 9.85, 1.71 and 10.32 points from 2021 to 2024 — then lost by 8.12 in 2025. Mean absolute gap: 7.63 points a year on identical stocks.
Across six matched hedged and unhedged pairs from one issuer: $592.56bn unhedged against $9.83bn hedged. Sixty to one. The hedged version holds 1.63% of the money.
And the usual explanation for it is about a quarter right. Over ten years the hedged advantage of 2.748 points a year decomposes into +2.058 points of hedge carry (74.9%) and +0.671 points from the dollar's actual movement (24.4%). Three quarters of it is an interest-rate differential, not a currency view — and it narrows when that differential narrows, whatever the dollar does.
Four semiconductor holdings — TSMC, Samsung, SK Hynix and Samsung preferred — are 28.71% of the main emerging-market index. Add MediaTek, Delta and Hon Hai and it is 31.86%, which is 84.9% of the entire top ten. Information technology is 41.56% of the index; Taiwan and Korea together are 48.28%.
A client who owns an AI fund and adds an emerging-market fund for diversification has increased that exposure, not reduced it.
It moved fast. In twenty-two months the top ten went 26.14% → 37.53%, technology 23.71% → 41.56%, Taiwan and Korea 29.11% → 48.28%.
One index provider classifies South Korea as developed; another classifies it as emerging. So one major "emerging markets" index holds no Korea at all.
The two indexes, both called emerging markets, differed by 7.86 points in calendar 2025 — a gap created by a classification decision neither buyer made.
Over the same twelve months the Federal Reserve's broad dollar index fell 1.215% while its advanced foreign economies index rose 1.364%. The basket relevant to a developed- international allocation lost ground to the dollar, led by the yen at −8.17% on a 23.4% weight.
Using the broad index to describe a developed-international allocation states the opposite of what happened. It is the single easiest error to make in this subject, and it is in print here because we came close to making it.
Verification. 951 automated checks across two research passes, none failing. 33 planted mutations, all 33 caught — after four rounds in which the harnesses exposed real flaws in their own checkers. Eight errors were found and corrected inside the packs. Several issuers and one index provider blocked automated access; nothing was bypassed, and the data was rebuilt from the regulator's own portfolio filings, which proved the better source.
Disclosures. The author holds no position in any fund or security named here. No issuer payment, no advertising. Impersonal research, identical for every purchaser, tailored to no one. No statement about what any reader should hold. Finnacl Research is not an investment adviser.
The full report adds the eleven-fund snapshot series ordered by American weight, the concentration comparison, the adviser chapter, and the complete evidence appendix.